- Home
- FOLD vs HCC Comparison
FOLD vs HCC Comparison
Compare FOLD & HCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOLD | HCC |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Coal Mining |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.7B |
| IPO Year | 2006 | 2017 |
Fundamental Metrics
Financial Performance| Metric | FOLD | HCC |
|---|---|---|
| Price | $14.46 | $85.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $27.25 | ★ $95.29 |
| AVG Volume (30 Days) | ★ 2.6M | 686.2K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ 1.08 |
| Revenue | N/A | ★ $1,310,043,000.00 |
| Revenue This Year | $20.50 | $59.88 |
| Revenue Next Year | $18.59 | $8.82 |
| P/E Ratio | ★ N/A | $81.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.66 | $43.14 |
| 52 Week High | $14.48 | $105.35 |
Technical Indicators
Market Signals| Indicator | FOLD | HCC |
|---|---|---|
| Relative Strength Index (RSI) | 66.60 | 43.40 |
| Support Level | $14.21 | $84.15 |
| Resistance Level | N/A | $85.86 |
| Average True Range (ATR) | 0.02 | 4.47 |
| MACD | -0.01 | -1.01 |
| Stochastic Oscillator | 75.00 | 18.45 |
Price Performance
Historical ComparisonAbout FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About HCC Warrior Met Coal Inc.
Warrior Met Coal Inc produces and exports met or steelmaking coal, which is used as a component for steel production by metal manufacturers in Europe, South America, and Asia. The company is involved in longwall mining operations in its underground mines based in Alabama, Mine No. 4, Mine No. 7, and Blue Creek. Additionally, its natural gas operations remove and sell natural gas from owned and leased coal seams by reducing natural gas levels in its mines. The company generates revenue mainly through the production of steelmaking coal for sale to the steel industry. Geographically, the firm generates maximum revenue from its customers in Asia, followed by Europe, South America, and the United States.